J. Basuyau, E. Mallet, M. Leroy, and . Brunelle, Reference Intervals for Serum Calcitonin in Men, Women, and Children, Clinical Chemistry, vol.50, issue.10, pp.1828-1830, 2004.
DOI : 10.1373/clinchem.2003.026963

S. Choi, S. Yoon, P. Calabrese, and . Arnheim, Positive selection for new disease 447 mutations in the human germline: evidence from the heritable cancer syndrome multiple 448

G. Chong, O. Beahrs, G. Sizemore, and L. Woolner, Medullary carcinoma of the thyroid gland, Cancer, vol.102, issue.3, pp.695-704, 1975.
DOI : 10.7326/0003-4819-78-4-561

S. Clarke, P. Mondellini, and J. Leyland, RET is constitutively activated by novel tandem 456 mutations that alter the active site resulting in multiple endocrine neoplasia type 2B, Cancer, pp.1017-1023, 2006.

E. Uberti and I. Ceccherini, results from the ItaMEN network analysis on the prevalence of different genotypes and 589 phenotypes, Multiple endocrine neoplasia type 2 syndromes, pp.588-301, 2010.

S. Iorcansky, Very early detection of RET proto-oncogene mutation is crucial for 592 preventive thyroidectomy in multiple endocrine neoplasia type 2 children: presence of C-cell 593 malignant disease in asymptomatic carriers, Cancer, vol.94, pp.323-330, 2002.

M. Habra and C. Jimenez, The characterization of pheochromocytoma and its impact on 611 overall survival in multiple endocrine neoplasia type 2, J Clin Endocrinol Metab, vol.98, pp.1813-612, 2013.

S. Thosani, M. Ayala-ramirez, A. Roman-gonzalez, S. Zhou, N. Thosani et al., Constipation: an overlooked, unmanaged symptom of patients with pheochromocytoma and sympathetic paraganglioma, European Journal of Endocrinology, vol.173, issue.3, pp.2015-377
DOI : 10.1002/bjs.6480

S. Waguespack and G. Cote, 2017 Medullary Thyroid Carcinoma in MEN2A: ATA Moderate 618 or High-Risk RET Mutations Do Not Predict Disease Aggressiveness, J Clin Endocrinol Metab, p.619

S. Waguespack, T. Rich, N. Perrier, C. Jimenez, and G. Cote, Management of medullary medullary thyroid cancer: a randomized, double-blind phase III trial, J Clin Oncol, vol.30, pp.134-141, 2011.

E. Williams and D. Pollock, Multiple mucosal neuromata with endocrine tumours: A syndrome allied to von Recklinghausen's disease, The Journal of Pathology and Bacteriology, vol.102, issue.1, pp.71-80, 1966.
DOI : 10.1001/archinte.1940.00190120040004

C. Wray, T. Rich, S. Waguespack, J. Lee, N. Perrier et al., Failure to Recognize Multiple Endocrine Neoplasia 2B: More Common Than We Think?, Annals of Surgical Oncology, vol.17, issue.8, pp.293-301, 2008.
DOI : 10.1016/S0002-9440(10)64176-4
URL : http://www.froedtert.com/upload/docs/services/cancer/publications/evans-wray-men.pdf

D. Chevenne, V. Barbu, and P. Guillausseau, Medullary thyroid carcinoma identified 637 within the first year of life in children with hereditary multiple endocrine neoplasia type 2A 638 (codon 634) and 2B, Eur J Endocrinol, vol.160, pp.807-813, 2009.

A. Znaczko, D. Donnelly, and P. Morrison, Epidemiology, Clinical Features, and Genetics of Multiple Endocrine Neoplasia Type 2B in a Complete Population, The Oncologist, vol.19, issue.12, pp.1284-1286, 2014.
DOI : 10.1634/theoncologist.2014-0277